| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABCF2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | CEP250 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | EDA2R | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | EIF2S3 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | A3GALT2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | ADAM9 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PKD1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | DNAJC5 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | MMP11 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
